Hypertension en high blood pressure
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age of 18 years or older 2. Documented medical history of hypertension in local hospital electronic patient record 3. Stable dose of anti-hypertensive medication for at least 2 months (includes no current antihypertensive medication, diagnosis hypertension is enough) 4. SBP>90 and 60 and
Exclusion criteria
Exclusion criteria: 1. SBP >180 mmHg and/or DBP >110mmHg at inclusion screening visit (attended AOBP). 2. Any BP that according to the treating physician is not adequately controlled and needs medication adjustment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main study parameters/endpoints: The main study parameters are twofold: (1) Mean difference between HBPM and ABPM values calculated with the Bland-Altman method (2) Mean standard deviation (SD) of the mean difference between HBPM and ABPM calculated with the Bland-Altman method. - Both expressed in mmHg for both SB and DBP (see primary objective chapter 2). - The HBPM value is a 7-day average of systolic and diastolic BP - The ABPM value is an average BP measured by 24-hour ambulatory measurements | — |
Secondary
| Measure | Time frame |
|---|---|
| For all of the secondary objectives formulated in chapter 2 (objective A, B, C, D, E, F, G, H, I, J) the study parameters are the same as the main study parameters. For the last secondary objectives K the study parameters are: K: To investigate if a different protocol than the standard 7-day HBPM protocol results in clinically acceptable ( | — |
Countries
Netherlands